ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681231 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681231; 2) Community: the network communities that were significantly associated with the response to NSC 681231; 3) Molecule: the relationships between components within communities and NSC 681231; 4) MDR: the compounds that were significantly associated with the NSC 681231.

NSC Compound Enrichment Correlation
NSC 710547 2H,6H-Pyrazolo[3,4,5-mn]pyrimido[5,6,1-de]acridine- 5,7-dione, 11-methoxy-2,6-bis[2-(dimethylamino)ethyl]- 0.0376362543535815 -0.3051806
NSC 711830 Null 0.0376362543535815 0.35170334
NSC 71795 Ellipticine 0.0376362543535815 -0.37922761
NSC 724602 S-(dimethylarsino)-3-mercapto-1,2-propyl dibenzoate 0.0376362543535815 0.31743641
NSC 729184 4-Chloro-5-phenoxy-3H-1,2-dithiole-3-thione 0.0376362543535815 0.30976404
NSC 743558 Null 0.0376362543535815 0.3029634
NSC 760978 Null 0.0376362543535815 0.3784594
NSC 681635 Camptothecin Derivative 0.0382675857669585 -0.0097977926
NSC 684902 Null 0.0382675857669585 0.39588918
NSC 694002 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0382675857669585 0.21703452
Total:72  Current:54    [First] [Prev] [Next] [Last]